Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16996287 | 1.00 | PDK2 (0.33) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16802267 | 0.95 | KDM4E (0.33) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16996288 | 0.94 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL21968788 | 0.94 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL17033065 | 0.94 | PDK2 (0.36) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16996267 | 0.94 | PDK2 (0.38) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16996581 | 0.94 | PDK2 (0.35) | PDK2 | |
| SCHEMBL25124588 | 0.94 | PDK2 (0.35) | PDK2 | |
| SCHEMBL17733238 | 0.94 | PDK2 (0.38) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL18212143 | 0.94 | PDK2 (0.38) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-20230210002-A1 | COMPOSITION, AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230111469-A1 | Organic Electronic Device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-11575087-B1 | Organic electroluminescence device, light emitting device, organic electroluminescence display device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | HTR1D, EHD1, HTR3D | PDK2 1203/4885KDM4E 3361/4885MEN1 451/4885 |
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RPS12, TCF12, RRP12 | PDK2 3188/4885KDM4E 2161/4885MEN1 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.